Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Effects of methylation on expression of TMS1/ASC in human breast cancer cells

Abstract

Gene silencing associated with aberrant methylation of promoter region CpG islands is one mechanism in which tumor suppressor genes are inactivated in human cancers. Recently, we identified a novel gene, Target of Methylation-associated Silencing-1 (TMS1) (also called ASC), which is aberrantly methylated and silenced in human breast cancers. To further investigate the mechanism of TMS1 silencing, we defined the transcription initiation site and detailed the DNA methylation pattern of the TMS1 CpG island in normal breast epithelial cells, breast cancer cell lines, and primary tumors. We find that in normal cells, the TMS1 CpG island lies within a 1.2 kb unmethylated domain, the 5′ boundary of which is in close proximity to the transcription initiation site. In breast cancer cell lines, this boundary appeared to be unstable in that methylation tended to accumulate in the 5′ end of the CpG island relative to normal epithelial cells. In contrast, the 3′ methylation boundary remained intact. Gene silencing was not correlated with the methylation of specific CpG sites nor the inability to transactivate the TMS1 promoter, but was correlated with the percentage of alleles in the population exhibiting dense methylation across the entire CpG island. Using 5-aza-deoxycytidine to reactivate TMS1 in methylated and silent cell lines, and a cassette methylation strategy to determine the impact of methylation on different parts of the promoter, we find that demethylation of a small region immediately surrounding the transcription start site is critical to TMS1 expression. Our data support the idea that gene silencing and dense methylation are tightly coupled events that affect individual chromosomal copies of TMS1 in an all-or-none manner. The transition to this stably repressed state may be facilitated by spreading of methylation into the proximal promoter and direct effects of methylation on TMS1 transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Baylin SB, Herman JG, Graff JR, Vertino PM and Issa JP . (1998). Adv. Cancer Res., 72, 141–196.

  • Bender CM, Gonzalgo ML, Gonzales FA, Nguyen CT, Robertson KD and Jones PA . (1999). Mol. Cell. Biol., 19, 6690–6698.

  • Bird A . (2002). Genes Dev., 16, 6–21.

  • Bird AP . (1986). Nature, 321, 209–213.

  • Bird AP and Wolffe AP . (1999). Cell, 99, 451–454.

  • Cameron EE, Baylin SB and Herman JG . (1999). Blood, 94, 2445–2451.

  • Campanero MR, Armstrong MI and Flemington EK . (2000). Proc. Natl. Acad. Sci. USA, 97, 6481–6486.

  • Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–159.

  • Conway KE, McConnell BB, Bowring CE, Donald CD, Warren ST and Vertino PM . (2000). Cancer. Res., 60, 6236–6242.

  • Curradi M, Izzo A, Badaracco G and Landsberger N . (2002). Mol. Cell. Biol., 22, 3157–3173.

  • Dammann R, Yang G and Pfeifer GP . (2001). Cancer Res., 61, 3105–3109.

  • Danam RP, Qian XC, Howell SR and Brent TP . (1999). Mol. Carcinogen., 24, 85–89.

  • Di Fiore B, Palena A, Felsani A, Palitti F, Caruso M and Lavia P . (1999). Nucleic Acids Res., 27, 2852–2859.

  • Eden S and Cedar H . (1994). Curr. Opin. Genet. Dev., 4, 255–259.

  • Feng Q, Cao R, Xia L, Erdjument-Bromage H, Tempst P and Zhang Y . (2002). Mol. Cell. Biol., 22, 536–546.

  • Ferguson AT, Vertino PM, Spitzner JR, Baylin SB, Muller MT and Davidson NE . (1997). J. Biol. Chem., 272, 32260–32266.

  • Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT and Jones PA . (1998). Cancer Res., 58, 1245–1252.

  • Han L, Lin IG and Hsieh CL . (2001). Mol. Cell. Biol., 21, 3416–3424.

  • Herman JG, Graff JR, Myohanen S, Nelkin BD and Baylin SB . (1996). Proc. Natl. Acad. Sci. USA, 93, 9821–9826.

  • Hsieh CL . (1994). Mol. Cell. Biol., 14, 5487–5494.

  • Ingvarsson S . (1999). Semin. Cancer Biol., 9, 277–288.

  • Jones PA and Laird PW . (1999). Nat. Genet., 21, 163–167.

  • Kass SU, Goddard JP and Adams RL . (1993). Biochem. Soc. Trans., 21, 9S.

  • Kass SU, Landsberger N and Wolffe AP . (1997). Curr. Biol., 7, 157–165.

  • Kinoshita H, Shi Y, Sandefur C, Meisner LF, Chang C, Choon A, Reznikoff CR, Bova GS, Friedl A and Jarrard DF . (2000). Cancer Res., 60, 3623–3630.

  • Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J and Polyak K . (2001). Proc. Natl. Acad. Sci. USA, 98, 9796–9801.

  • Mann JR, Szabo PE, Reed MR and Singer-Sam J . (2000). Crit. Rev. Eukaryot. Gene. Expr., 10, 241–257.

  • Martin AM and Weber BL . (2000). J. Natl. Cancer Inst., 92, 1126–1135.

  • Masumoto J, Taniguchi S, Ayukawa K, Sarvotham H, Kishino T, Niikawa N, Hidaka E, Katsuyama T, Higuchi T and Sagara J . (1999). J. Biol. Chem., 274, 33835–33838.

  • McConnell BB and Vertino PM . (2000). Cancer Res., 60, 6243–6247.

  • Schmitt AO, Specht T, Beckmann G, Dahl E, Pilarsky CP, Hinzmann B and Rosenthal A . (1999). Nucleic Acids Res., 27, 4251–4260.

  • Song JZ, Stirzaker C, Harrison J, Melki JR and Clark SJ . (2002). Oncogene, 21, 1048–1061.

  • Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z and Alnemri ES . (2002). J. Biol. Chem., 277, 21119–21122.

  • Stimson KM and Vertino PM . (2002). J. Biol. Chem., 277, 4951–4958.

  • van ’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R and Friend SH . (2002). Nature, 415, 530–536.

  • Wade PA . (2001). Oncogene, 20, 3166–3173.

  • Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F and Wolffe AP . (1999). Nat. Genet., 23, 62–66.

  • Wang L, Manji G, Grenier JM, Al-Garawi A, Merriam S, Lora JM, Geddes BJ, Briskin M, DiStefano PS and Bertin J . (2002). J. Biol. Chem., 17, 17.

  • Yang X, Yan L and Davidson NE . (2001). Endocr. Relat. Cancer, 8, 115–127.

  • Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A and Reinberg D . (1999). Genes Dev., 13, 1924–1935.

Download references

Acknowledgements

We thank Annalisa Stone for excellent technical assistance and Dr. Paraskevi Giannakakou for her critical review of the manuscript. This work was supported in part by PHS Grant 1RO1 CA77337 from the National Cancer Institute and funds from the Avon Foundation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paula M Vertino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levine, J., Stimson-Crider, K. & Vertino, P. Effects of methylation on expression of TMS1/ASC in human breast cancer cells. Oncogene 22, 3475–3488 (2003). https://doi.org/10.1038/sj.onc.1206430

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206430

Keywords

This article is cited by

Search

Quick links